{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:20:02Z","timestamp":1782318002443,"version":"3.54.5"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154986","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T17:45:54Z","timestamp":1462470354000},"page":"e0154986","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Young Youn","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Wook","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum-Youn","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,5]]},"reference":[{"issue":"9822","key":"ref1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"A Forner","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/gut.48.1.103","article-title":"Hepatocellular carcinoma in Central Europe: prognostic features and survival","volume":"48","author":"M Schoniger-Hekele","year":"2001","journal-title":"Gut"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/TP.0000000000000785","article-title":"Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients","volume":"100","author":"M Ghabril","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"Journal of hepatology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"J Bruix","year":"2012","journal-title":"Journal of hepatology"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ejca.2011.12.006","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial","volume":"48","author":"AL Cheng","year":"2012","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"JM Llovet","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"AL Cheng","year":"2009","journal-title":"The Lancet Oncology"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3350\/cmh.2015.21.2.115","article-title":"New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"HY Woo","year":"2015","journal-title":"Clinical and molecular hepatology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00432-010-0868-x","article-title":"An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"137","author":"DX Lin","year":"2011","journal-title":"Journal of cancer research and clinical oncology"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1245\/s10434-010-0940-4","article-title":"Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"17","author":"J Shi","year":"2010","journal-title":"Annals of surgical oncology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3350\/cmh.2016.22.1.160","article-title":"Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"J Lee","year":"2016","journal-title":"Clinical and molecular hepatology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"M Omata","year":"2010","journal-title":"Hepatology international"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"J Luo","year":"2011","journal-title":"Annals of surgical oncology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.12111550","article-title":"Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib","volume":"263","author":"M Pinter","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"R Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"V Mazzaferro","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/liv.12574","article-title":"Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis","volume":"35","author":"A Gramenzi","year":"2015","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"R Salem","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/liv.12637","article-title":"In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?","volume":"35","author":"A El Fouly","year":"2015","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","article-title":"Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization","volume":"29","author":"K Sato","year":"2006","journal-title":"Cardiovascular and interventional radiology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"P Hilgard","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref24","article-title":"Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis","author":"N Kokabi","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2012.09.003","article-title":"Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression","volume":"58","author":"K Memon","year":"2013","journal-title":"Journal of hepatology"},{"key":"ref26","article-title":"A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or Sorafenib","author":"M de la Torre","year":"2016","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/COC.0b013e3182a78dba","article-title":"Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study","volume":"38","author":"Y Kim do","year":"2015","journal-title":"American journal of clinical oncology"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1148\/radiol.13131760","article-title":"Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting","volume":"271","author":"HJ Yang","year":"2014","journal-title":"Radiology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"B Sangro","year":"2012","journal-title":"Journal of hepatology"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"e113926","DOI":"10.1371\/journal.pone.0113926","article-title":"Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases","volume":"9","author":"JJ Yoo","year":"2014","journal-title":"PloS one"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4254\/wjh.v7.i11.1553","article-title":"Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein","volume":"7","author":"SJ Yu","year":"2015","journal-title":"World journal of hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:03:39Z","timestamp":1540325019000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154986"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154986","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,5]]}}}